Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.

Sauter AW, Spira D, Schulze M, Pfannenberg C, Hetzel J, Reimold M, Klotz E, Claussen CD, Horger MS.

Eur J Nucl Med Mol Imaging. 2013 May;40(5):677-84. doi: 10.1007/s00259-012-2318-2. Epub 2013 Jan 10.

PMID:
23306806
2.

Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.

Sauter AW, Winterstein S, Spira D, Hetzel J, Schulze M, Mueller M, Pfannenberg C, Claussen CD, Klotz E, Hann von Weyhern C, Horger MS.

J Nucl Med. 2012 Apr;53(4):521-9. doi: 10.2967/jnumed.111.097865. Epub 2012 Mar 13.

3.

Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.

Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.

Ann Nucl Med. 2009 Aug;23(6):523-31. doi: 10.1007/s12149-009-0268-y. Epub 2009 May 15.

PMID:
19444550
4.

Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.

Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D, Baron O, Despins P.

Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6. doi: 10.1016/j.ejcts.2009.05.044. Epub 2009 Jul 25.

PMID:
19632852
5.

Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.

Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.

J Nucl Med. 2011 Oct;52(10):1520-5. doi: 10.2967/jnumed.111.092593. Epub 2011 Sep 9.

7.

Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.

Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.

Ann Nucl Med. 2009 Jul;23(5):427-35. doi: 10.1007/s12149-009-0260-6. Epub 2009 May 13.

PMID:
19437097
8.

Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.

Takenaka T, Yano T, Morodomi Y, Ito K, Miura N, Kawano D, Shoji F, Baba S, Abe K, Honda H, Maehara Y.

Surg Today. 2012 Oct;42(10):934-9. doi: 10.1007/s00595-012-0277-7. Epub 2012 Aug 3.

PMID:
22864936
9.

[Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer].

Zhi XY, Liu BD, Xu QS, Zhang Y, Su L, Wang HR, Hu M.

Zhonghua Yi Xue Za Zhi. 2005 Aug 3;85(29):2026-9. Chinese.

PMID:
16313793
10.

Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.

Lee SM, Park CM, Paeng JC, Im HJ, Goo JM, Lee HJ, Kang CH, Kim YW, Kim JI.

Eur Radiol. 2012 Jul;22(7):1556-63. doi: 10.1007/s00330-012-2395-4. Epub 2012 Feb 24.

PMID:
22358427
11.

Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.

Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Kozuka T, Hosoki T, Hasegawa Y, Takami M, Tomita Y, Kodama K.

Lung Cancer. 2011 Mar;71(3):333-7. doi: 10.1016/j.lungcan.2010.06.008. Epub 2010 Jul 8.

PMID:
20619479
12.

Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.

Kuo WH, Wu YC, Wu CY, Ho KC, Chiu PH, Wang CW, Chang CJ, Yu CT, Yen TC, Lin C.

Acad Radiol. 2012 Jun;19(6):685-92. doi: 10.1016/j.acra.2012.02.013. Epub 2012 Mar 28.

PMID:
22459646
13.

Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease.

An YS, Sun JS, Park KJ, Hwang SC, Park KJ, Sheen SS, Lee S, Lee KB, Yoon JK.

Lung. 2008 Sep-Oct;186(5):327-36. doi: 10.1007/s00408-008-9109-3. Epub 2008 Aug 1.

PMID:
18670805
14.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
15.

Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.

Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, Sato T, Watanabe K, Kawai H, Sato S, Kanazawa S.

Clin Nucl Med. 2009 Apr;34(4):216-21. doi: 10.1097/RLU.0b013e31819a1f3d.

PMID:
19300050
16.

[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].

Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):306-9. Chinese.

PMID:
18788639
17.

Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.

Bryant AS, Cerfolio RJ, Klemm KM, Ojha B.

Ann Thorac Surg. 2006 Aug;82(2):417-22; discussion 422-3.

PMID:
16863739
18.

Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.

Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.

Radiother Oncol. 2012 Feb;102(2):246-50. doi: 10.1016/j.radonc.2011.10.016. Epub 2011 Nov 17.

PMID:
22100657
19.

Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.

Saydam O, Gokce M, Kilicgun A, Tanriverdi O.

Med Oncol. 2012 Jun;29(2):589-94. doi: 10.1007/s12032-011-9879-y. Epub 2011 Mar 6.

PMID:
21380783
20.

The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.

Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ.

Radiother Oncol. 2000 Jun;55(3):317-24.

PMID:
10869746
Items per page

Supplemental Content

Write to the Help Desk